Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis
Open accessThe DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
Hypertension and atherosclerosis are among the most common causes of mortality in both developed and developing countries. Experimental animal models of hypertension and atherosclerosis have become a valuable tool for providing information on etiology, pathophysiology, and complications of the disease and on the efficacy and mechanism of action of various drugs and compounds used in treatment. An animal model has been developed to study hypertension and atherosclerosis for several reasons. Compared to human models, an animal model is easily manageable, as compounding effects of dietary and environmental factors can be controlled. Blood vessels and cardiac tissue samples can be taken for detailed experimental and biomolecular examination. Choice of animal model is often determined by the research aim, as well as financial and technical factors. A thorough understanding of the animal models used and complete analysis must be validated so that the data can be extrapolated to humans. In conclusion, animal models for hypertension and atherosclerosis are invaluable in improving our understanding of cardiovascular disease and developing new pharmacological therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although these genetically modified models could capture some of the features of the CVD phenotype in humans, they typically do not resemble all aspects of CVDs in humans [86,87].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Stoschitzky, K. (2000) · Handbooks in Pharmacology and Toxicology · doi:10.1201/9781420036961.ch18 · Cited by 2,956
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860 · cited 1×
“Therefore, animals are good models for the study of human diseases.”
BackgroundDevelopment of a Strain of Spontaneously Hypertensive Rats
OKAMOTO, K., & AOKI, K. (1963) · Japanese Circulation Journal · doi:10.1253/jcj.27.282 · Cited by 2,545 · cited 3×
“Genetic hypertension (i) SHR (ii) Dahl salt-sensitive (iii) Transgenic (i) SHR is developed by inbreeding Wistar rats (brother-to-sister) with the highest BP [28].”
BackgroundInfluentialInitial sequence of the chimpanzee genome and comparison with the human genome
The Chimpanzee Sequencing and Analysis Consortium (2005) · Nature · doi:10.1038/nature04072 · Cited by 2,459 · cited 1×
“For example, chimpanzees and mice share about 99% and 98% of DNA with humans, respectively [4, 5].”
BackgroundSpontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237 · cited 2×
“They exhibit a higher total plasma cholesterol concentration of 11mM compared to 2mM in their parent C57BL/6 mice [114].”
BackgroundSTUDIES ON EXPERIMENTAL HYPERTENSION
Goldblatt, H., Lynch, J., Hanzal, R. F., & Summerville, W. W. (1934) · Journal of Experimental Medicine · doi:10.1084/jem.59.3.347 · Cited by 2,142 · cited 1×
“developed a hypertension model through partial constriction of the renal artery in dog [38].”
BackgroundAnimal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
Research works printed but not linked: 2
- Gross F. Gross F. Robertson J. I. S. Experimental models of hypertension and their use in the evaluation of antihypertensive drugs Arterial Hypertension: The Gestation and Birth of a WHO Expert Committee Report 1980 Boston, Mass, USA G.K. Hall Medical Publishers 198 208
- Ignatowski A. C. Influence of animal food on the organism of rabbits Izvestia Imperatorskoi Voenno-Medicinskoi Akademii (St Petersburg) 1908 16 154 176
Cited by
Myocardial Fibrosis: Biomedical Research from Bench to Bedside
Gyöngyösi, M., Winkler, J., Ramos, I., Do, Q.-T., Firat, H., McDonald, K., González, A., Thum, T., Díez, J., Jaisser, F., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.696 · Cited by 397
Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models
Caddeo, S., Boffito, M., & Sartori, S. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00040 · Cited by 285
Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis
von Scheidt, M., Zhao, Y., Kurt, Z., Pan, C., Zeng, L., Yang, X., Schunkert, H., & Lusis, A. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.001 · Cited by 221
“Although the causes of hypertension in those models are different, acceleration of atherosclerosis was a consistent finding (Leong et al., 2015; Weiss et al., 2001; Wiesel et al., 1997).”
BackgroundCardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Mouse models of atherosclerosis: a historical perspective and recent advances
Lee, Y. T., Lin, H. Y., Chan, Y. W. F., Li, K. H. C., To, O. T. L., Yan, B. P., Liu, T., Li, G., Wong, W. T., Keung, W., et al. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-016-0402-5 · Cited by 167
Normal-weight obesity syndrome: diagnosis, prevalence, and clinical implications
Franco, L. P., Morais, C. C., & Cominetti, C. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw019 · Cited by 156
Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research
Rai, V., Sharma, P., Agrawal, S., & Agrawal, D. K. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2849-0 · Cited by 115
“Replacement, reduction, and refinement must also be taken into consideration [8, 80].”
Metabolomics of mitochondrial disease
Esterhuizen, K., van der Westhuizen, F. H., & Louw, R. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.05.012 · Cited by 106
Hamjane, N., Benyahya, F., Nourouti, N. G., Mechita, M. B., & Barakat, A. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104023 · Cited by 91
Giles, D. A., Ramkhelawon, B., Donelan, E. M., Stankiewicz, T. E., Hutchison, S. B., Mukherjee, R., Cappelletti, M., Karns, R. A., Karp, C. L., Moore, K. J., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.09.008 · Cited by 85
“However, the same cannot be accomplished for atherosclerosis, as WT mice are highly resistant to atherosclerosis development, even when fed an obesogenic diet [4].”
BackgroundLi, D., Wu, J., Bai, Y., Zhao, X., & Liu, L. (2014) · Journal of Visualized Experiments · doi:10.3791/51357 · Cited by 75
Engineering in vitro vascular microsystems
Liu, Q., Ying, G., Hu, C., Du, L., Zhang, H., Wang, Z., Yue, H., Yetisen, A. K., Wang, G., Shen, Y., et al. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-00956-w · Cited by 71
“Additionally, the extensive use of experimental animals raises ethical concerns 3 .”
Macrophage Depletion Lowered Blood Pressure and Attenuated Hypertensive Renal Injury and Fibrosis
Huang, L., Wang, A., Hao, Y., Li, W., Liu, C., Yang, Z., Zheng, F., & Zhou, M.-S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00473 · Cited by 67
“While extrapolation between experimental animal studies and human hypertension is always speculative, since many of the animal models have been developed using the etiological factors which have been hypothesized to have a contributory role in human hypertension (Leong et al., 2015).”
BackgroundEssential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction
Kassan, M., Ait‐Aissa, K., Radwan, E., Mali, V., Haddox, S., Gabani, M. H., Zhang, W., Belmadani, S., Irani, K., Trebak, M., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307869 · Cited by 65
“1900 Hypertension is a major risk factor for cardiovascular complications, including heart failure and stroke in animal models and patients.(1,2) Vascular reactivity is of paramount importance in regulating local blood flow and ensuring constant tissue perfusion.”
BackgroundPathophysiology and genetics of salt-sensitive hypertension
Maaliki, D. S., Itani, M. M., & Itani, H. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1001434 · Cited by 67
“Removal of kidney mass decreases renin production and fluid excretion, producing a volume overload and low renin form of HTN (Chamorro et al., 2004; Sun and Zhang, 2005; Leong et al., 2015).”
BackgroundAnimal models for neonatal brain injury induced by hypoxic ischemic conditions in rodents
Hamdy, N., Eide, S., Sun, H., & Feng, Z. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113457 · Cited by 65
Targeting toll‐like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension?
Nunes, K. P., de Oliveira, A. A., Mowry, F. E., & Biancardi, V. C. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14438 · Cited by 65
Hypertension and Its Impact on Stroke Recovery: From a Vascular to a Parenchymal Overview
Maïer, B., & Kubis, N. (2019) · Neural Plasticity · doi:10.1155/2019/6843895 · Cited by 63
“The Dahl salt-sensitive rats, derived from SpragueDawley rats, become hypertensive when a normal salt intake is given [28] and a severe and morbid hypertension with a high salt intake [28].”
BackgroundMethodMyocardial Disease and Long-Distance Space Travel: Solving the Radiation Problem
Meerman, M., Gartner, T. C. L. B., Buikema, J. W., Wu, S. M., Siddiqi, S., Bouten, C. V. C., Grande-Allen, K. J., Suyker, W. J. L., & Hjortnaes, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.631985 · Cited by 58
“To study the pathophysiology of atherosclerosis, atherosclerosis-prone mouse models such as the apolipoprotein E-deficient (apoE) model have to be used since regular mouse models are relatively resistant to atherosclerosis (64).”
BackgroundHyperhomocysteinemia and cardiovascular disease in animal model
Azad, M. A. K., Huang, P., Liu, G., Ren, W., Teklebrh, T., Yan, W., Zhou, X., & Yin, Y. (2017) · Amino Acids · doi:10.1007/s00726-017-2503-5 · Cited by 53
“2010; Zidan and Elnegris 2015), and in large animals, such as rabbits, swine, and dogs (Zhang et al. 2014; Sipahioglu et al. 2005; Leong et al. 2015).”
BackgroundGenetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 60
Udomkasemsab, A., & Prangthip, P. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.09.004 · Cited by 57
Animal models for evaluation of oral delivery of biopharmaceuticals
Rønholt, S., Nielsen, L. H., & Nielsen, H. M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.025 · Cited by 51
Animal models for the study of primary and secondary hypertension in humans
Lin, H. Y., Lee, Y. T., Chan, Y. W. F., & Tse, G. (2016) · Biomedical Reports · doi:10.3892/br.2016.784 · Cited by 54
“Animal models of hypertension can be categorised according to aetiology (13) (Fig.”
Liu, L., Lü, Y., Bi, X., Xu, M., Yu, X., Xue, R., He, X., & Zang, W. (2017) · Scientific Reports · doi:10.1038/srep42553 · Cited by 51
Genetic Alterations in Oxidant and Anti-Oxidant Enzymes in the Vascular System
Awad, M. A., Aldosari, S., & Abid, M. R. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00107 · Cited by 46
Ahmed, H. A., Ishrat, T., Pillai, B., Bunting, K. M., Patel, A., Vazdarjanova, A., Waller, J. L., Arbab, A. S., Ergul, A., & Fagan, S. C. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.007 · Cited by 41
“In addition, the evolution of behavioral and neuropathological characteristics as well as microstructural and cognitive changes are similar to those occurring in human neurodegenerative disorders and VCI [13].”
Dietary calcium affects body composition and lipid metabolism in rats
Alomaim, H., Griffin, P., Swist, E., Plouffe, L. J., Vandeloo, M., Demonty, I., Kumar, A., & Bertinato, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210760 · Cited by 43
Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish
Vedder, V. L., Aherrahrou, Z., & Erdmann, J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00109 · Cited by 39
Wu, Q., Yuan, X., Han, R., Zhang, H., & Xiu, R. (2019) · Epigenomics · doi:10.2217/epi-2019-0148 · Cited by 37
Wang, H., Sugimoto, K., Lu, H., Yang, W., Liu, J.-Y., Yang, H.-Y., Song, Y., Yan, D., Zou, T., & Shen, S. Q. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.044 · Cited by 33
“Identification of the relevant molecular biomarkers is necessary to develop novel therapeutic strategies for ameliorating endothelial dysfunction, which might impede or even reverse disease progression in atherosclerosis.(7)”
Backgroundde Almeida, C. L. B., Filho, V. C., Boeing, T., Mariano, L. N. B., da Silva, L. M., de Andrade, S. F., & de Souza, P. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.11.021 · Cited by 32
Approaching Sex Differences in Cardiovascular Non-Coding RNA Research
Jusić, A., Salgado‐Somoza, A., Paes, A. B., Stefanizzi, F. M., Martínez-Alarcón, N., Pinet, F., Martelli, F., Devaux, Y., Robinson, E. L., Novella, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144890 · Cited by 31
“Preferential use of male animal models in basic cardiovascular research can be explained by higher variability in fluctuating gonadal hormone levels which request female testing across the estrus cycle, as well as sample size and costs implications of planning sex-based analyses [111].”
Backgroundde Souza, P., da Silva, L. M., Boeing, T., Somensi, L. B., Cechinel‐Zanchett, C. C., Campos, A., Krueger, C. D. M. A., Bastos, J. K., Filho, V. C., & de Andrade, S. F. (2017) · Phytotherapy Research · doi:10.1002/ptr.5876 · Cited by 31
“Similarly, we also tested the effects of kaempferitrin in SHR, which has been widely used and accepted as a suitable model for the study of hypertension, because of its closeness with the pathophysiology of human’s disease (Dickhout and Lee, 1998; Kundu, 2008; Leong et al., 2015).”
MethodDiNatale, J. C., & Crowe-White, K. M. (2022) · Nitric Oxide · doi:10.1016/j.niox.2022.10.005 · Cited by 31
Toll-Like Receptor 4 and Blood Pressure: Lessons From Animal Studies
Nunes, K. P., de Oliveira, A. A., Lima, V. V., & Webb, R. C. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00655 · Cited by 28
Choi, S. Y., Kee, H. J., Sun, S., Seok, Y. M., Ryu, Y., Kim, G. R., Kee, S., Pflieger, M., Kurz, T., Kassack, M. U., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14188 · Cited by 28
Chen, L., Fang, Z., Wang, X., Sun, X., Ge, X., Cheng, C., & Hu, H. (2021) · Bioengineered · doi:10.1080/21655979.2021.1952917 · Cited by 28
de Almeida, C. L. B., Boeing, T., Somensi, L. B., Steimbach, V. M. B., da Silva, L. M., de Andrade, S. F., Monachè, F. D., Filho, V. C., & de Souza, P. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.03.004 · Cited by 26
Mechanism of herbal medicine on hypertensive nephropathy (Review)
Dong, Z., Dai, H., Feng, Z., Liu, W., Gao, Y., Liu, F., Zhang, Z., Zhang, N., Dong, X., Zhao, Q., et al. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11873 · Cited by 26
Santo, D. A. E., Cordeiro, G. S., dos Santos, L. S., Silva, R. T., Pereira, M. U., de Matos, R. J. B., Boaventura, G. T., & Medeiros, J. M. B. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110700 · Cited by 25
Sex differences in preclinical models of hypertension
Olivera, S., & Graham, D. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00770-1 · Cited by 25
“Due to this multifactorial nature, different animal models have been created in order to mimic specific contributing pathways involved in the hypertension disease process, including genetic mutations, the reninangiotensin-aldosterone system (RAAS) and elevated salt intake [5].”
BackgroundCho, K., Yadav, D., Kim, S., & Kim, J. (2018) · Molecules · doi:10.3390/molecules23051080 · Cited by 23
Laso-García, F., Diekhorst, L., Frutos, M. C. G.-D., Otero‐Ortega, L., Fuentes, B., Ares, G. R., Díez‐Tejedor, E., & Gutiérrez‐Fernández, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00332 · Cited by 23
Mehta, S., Srivastava, N., Bhatia, A., & Dhawan, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106561 · Cited by 23
Malik, A., Mehmood, M. H., Channa, H., Akhtar, M. S., & Gilani, A. H. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1644-0 · Cited by 24
Prouse, T., Majumder, S., & Majumder, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312736 · Cited by 22
ApoE/NOS3 Knockout Mice as a Novel Cardiovascular Disease Model of Hypertension and Atherosclerosis
Liu, K., Chen, B., Zeng, F., Wang, G., Wu, X., Liu, Y., Li, G., Yan, J., & Zhang, S. (2022) · Genes · doi:10.3390/genes13111998 · Cited by 23
González-Guerra, A., Roche-Molina, M., García-Quintáns, N., Sánchez‐Ramos, C., Martín-Pérez, D., Lytvyn, M., de Nicolás‐Hernández, J., Rivera, J., Arroyo, D. F., Sanz‐Rosa, D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168448 · Cited by 22
“Comprehensive understanding of the interaction between mild increase in BP and atherosclerosis requires experimental evidence based on new animal models of elevated BP [11,12] to test causal relationships.”
BackgroundRabadán-Chávez, G. M., Reyes‐Maldonado, E., Quevedo-Corona, L., Paniagua‐Castro, N., Escalona-Cardoso, G. N., & Jaramillo‐Flores, M. E. (2016) · Food & Function · doi:10.1039/c6fo01165a · Cited by 23
Morgan, H. L., Butler, E., Ritchie, S., Herse, F., Dechend, R., Beattie, E. C., McBride, M., & Graham, D. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10935 · Cited by 24
Allen, P. S., Dell’Italia, L. J., Esvelt, M. A., Conte, M. L., Cadillac, J. M., & Myers, D. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814338-4.00025-8 · Cited by 22
Aluko, E. O., Omóbòwálé, T. O., Oyagbemi, A. A., Adejumobi, O. A., Ajibade, T. O., & Fasanmade, A. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.001 · Cited by 21
The acute diuretic effects with low-doses of natural prenylated xanthones in rats
Mariano, L. N. B., Boeing, T., Filho, V. C., Niero, R., da Silva, L. M., & de Souza, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173432 · Cited by 20
Wang, Y., Wang, E., Zhang, Y., Madamsetty, V. S., Ji, B., Radisky, D. C., Grande, J. P., Misra, S., & Mukhopadhyay, D. (2018) · The FASEB Journal · doi:10.1096/fj.201800499r · Cited by 20
“To inducehypertension,we implanted osmotic minipumps in both control andNRP1mice to deliver recombinant ang II, the most commonly used vasopressor in experimental models of hypertension (16); a low dose of 500 ng/kg per minute was used.”
MethodIliev, A. A., Kotov, G. N., Dimitrova, I. N., & Landzhov, B. V. (2018) · Acta Histochemica · doi:10.1016/j.acthis.2018.10.004 · Cited by 19
Gutsol, A. A., Blanco, P. L., Hale, T. M., Thibodeau, J.-F., Holterman, C. E., Nasrallah, R., Corrêa, J. W. D. N., Afanasiev, S. A., Touyz, R. M., Kennedy, C., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264136 · Cited by 18
Pereira‐Silva, D. C., Machado‐Silva, R. P., Castro‐Pinheiro, C., & Fernandes‐Santos, C. (2019) · International Journal of Experimental Pathology · doi:10.1111/iep.12318 · Cited by 21
Nurfaradilla, S. A., Saputri, F. C., & Harahap, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/5013898 · Cited by 17
“One of the reasons of using animals in biomedical research is due to its similarities to human, particularly its similarity in anatomical basis and physiological functions with humans [11].”
BackgroundMethodSchlickmann, F., de Souza, P., Boeing, T., Mariano, L. N. B., Steimbach, V. M. B., Krueger, C. D. M. A., da Silva, L. M., de Andrade, S. F., & Filho, V. C. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12785 · Cited by 17
Horská, K., Kotolová, H., Karpíšek, M., Babinská, Z., Hammer, T., Procházka, J. H., Štark, T., Micale, V., & Kučerová, J. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115214 · Cited by 18
da Silva, R. D. C. V., Boeing, T., Mariano, L. N. B., Somensi, L. B., da Silva, L. M., & de Souza, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173469 · Cited by 16
Giménez, V. M. M., Marón, F. J. M., Menéndez, S. G., Mazzei, L. J., Guevara, M. A., Yunes, R., & Manucha, W. A. (2020) · Advances in Medical Sciences · doi:10.1016/j.advms.2020.12.003 · Cited by 16
Cojocaru, E., Leon, M. M., Ungureanu, C., Trandafirescu, M. F., Maștaleru, A., Trandafir, L. M., Petrariu, F. D., Bădulescu, O. V., & Filip, N. (2021) · Medicina · doi:10.3390/medicina57030239 · Cited by 17
“We analyzed many animal models discussed in the literature [21] and we chose the atherosclerosis experimental model proposed by Anitschkow in 1913 [22].”
MethodA piggyBac-based platform for genome editing and clonal rhesus macaque iPSC line derivation
Rodríguez-Polo, I., Mißbach, S., Petkov, S., Mattern, F., Maierhofer, A., Grządzielewska, I., Tereshchenko, Y., Urrutia-Cabrera, D., Haaf, T., Dressel, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94419-7 · Cited by 16
Phenelzine reduces the oxidative damage induced by peroxynitrite in plasma lipids and proteins
Mustafa, A., Al-Shboul, O. A., Alfaqih, M. A., Alqudah, M., & Al‐Dwairi, A. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1415939 · Cited by 16
“Indeed, several animal models of chronic diseases where oxidative stress plays a central role (Leong et al. 2015) exist and we could more thoroughly investigate the capacity of phenelzine to decrease the damaging effects of peroxynitrite in the plasma and/or other blood components in these models.”
BackgroundMicropatterning and Assembly of 3D Microvessels
Redd, M. A., Kotha, S. S., Phong, K. T., & Zheng, Y. Y. (2016) · Journal of Visualized Experiments · doi:10.3791/54457 · Cited by 15
Aluko, E. O., Adejumobi, O. A., & Fasanmade, A. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116753 · Cited by 15
A bivalent antihypertensive vaccine targeting L‐type calcium channels and angiotensin AT1 receptors
Wu, H., Wang, Y., Wang, G., Qiu, Z., Hu, X., Zhang, H., Yan, X., Ke, F., Zou, A., Wang, M., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14875 · Cited by 15
“In addition, Ang II‐induced hypertension is another commonly employed model of hypertension (Leong et al., 2015).”
BackgroundMethodInfluentialNamazi, F., Shomali, T., Taghikhani, P., & Nazıfı, S. (2018) · PubMed Central · doi:10.22038/ajp.2018.25213.1917 · Cited by 15
“Rats and mice are not good models for AS, because they are typically resistant to atherogenesis; therefore, other interventions, such as administration of vitamin D3, to promote vascular calcification is often required (Leong et al., 2015) which considerably elevates the rate of lesion generation.”
BackgroundInvestigative safety strategies to improve success in drug development
Atienzar, F., Delaunois, A. G., Brouta, F., Cornet, M., Fleurance, R., Gerets, H. H. J., Glineur, S., Hasselgren, C., Kießling, A., da Costa, A. N., et al. (2016) · JOURNAL OF MEDICINES DEVELOPMENT SCIENCES · doi:10.18063/jmds.v2i1.139 · Cited by 14
Eickelmann, C., Lieder, H. R., Sturek, M. S., Heusch, G., & Kleinbongard, P. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00719.2023 · Cited by 14
Whole-Body Vibration Training Increases Myocardial Salvage Against Acute Ischemia in Adult Male Rats
Shekarforoush, S., & Naghii, M. R. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180252 · Cited by 14
Paes, L., Lima, D. J. M. D. M., Matsuura, C., de Souza, M. D. G., Cyrino, F. Z. G. A., Barbosa, C., Ferrão, F. M., Bottino, D. A., Bouskela, E., & Farinatti, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0218228 · Cited by 15
Anti-apoptotic effects of BDNF-TrkB signaling in the treatment of hemorrhagic stroke
Hasegawa, Y., Cheng, C., Hayashi, K., Takemoto, Y., & Kim‐Mitsuyama, S. (2020) · Brain Hemorrhages · doi:10.1016/j.hest.2020.04.003 · Cited by 15
Characterization of Contractile Machinery of Vascular Smooth Muscles in Hypertension
Yang, Q., & Hori, M. (2021) · Life · doi:10.3390/life11070702 · Cited by 14
“Animals are used in biomedical research for the reasons of feasibility, similarities to humans and drug safety [125].”
BackgroundPai, A. V., West, C. A., de Souza, A. M. A., Cheng, X., West, D. A., Ji, H., Wu, X., Baylis, C., & Sandberg, K. L. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00449.2017 · Cited by 13
“To address this heterogeneity, various experimental rat models have been developed to investigate the genesis or pathophysiology of hypertension (29, 43).”
MethodParikh, M., Kura, B., Garg, B., Austria, J. A., Yu, L., Maddaford, T. G., Proctor, S. D., Netticadan, T., & Pierce, G. N. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108829 · Cited by 13
Zebrafish Model to Study Angiotensin II-Mediated Pathophysiology
Joshi, B., Wagh, G., Kaur, H., & Patra, C. (2021) · Biology · doi:10.3390/biology10111177 · Cited by 13
“There are many established rodent models to study hypertension [15,16].”
BackgroundBiomimetic microsystems for cardiovascular studies
Inbody, S. C., Sinquefield, B. E., Lewis, J. P., & Horton, R. E. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00026.2020 · Cited by 14
Hogue, T., Das, P., Reczek, S., Hampton‐Marcell, J., Ford, Y., Raval, D., Carroll, I. M., & Cook, M. D. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039759 · Cited by 12
“7 Gut microbiome and hypertension .”
Guiding Principles for Human and Animal Research During Pharmaceutical Product Development
Maheshwari, R., Gupta, A., Ganeshpurkar, A., Chourasiya, Y., Tekade, M., & Tekade, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814421-3.00018-x · Cited by 14
Zălar, D.-M., Pop, C., Buzdugan, E., Kiss, B., Ștefan, M.-G., Ghibu, S., Bâlteanu, V.-A., Crişan, D., Buruiană, A., Grozav, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143143 · Cited by 12
“Another advantage of rats is their very well characterized genome, which allows for relatively easy genetic manipulation [28].”
BackgroundKij, A., Bar, A., Przyborowski, K., Proniewski, B., Mateuszuk, Ł., Jasztal, A., Kieronska‐Rudek, A., Marczyk, B., Matyjaszczyk‐Gwarda, K., Tworzydło, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168664 · Cited by 12
“Accordingly, in our work in the murine model of Ang II-induced hypertension, we extend the evidence supporting the involvement of thrombin in endothelial dysfunction and excluded the role of thrombin in vascular remodelling and hypertension [26,27].”
BackgroundLim, X. R., Drumm, B. T., Sergeant, G. P., Hollywood, M. A., & Thornbury, K. D. (2022) · Physiological Reports · doi:10.14814/phy2.15504 · Cited by 14
Młynarczyk, M., & Kasacka, I. (2022) · Advances in Medical Sciences · doi:10.1016/j.advms.2022.01.001 · Cited by 13
Lin, S., Lin, S., Chen, C.-C., Fu, Y., & Weng, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8112003 · Cited by 12
“Common environmental stimuli include flashing lights, loud noises, restraints, cages, and high/low temperatures [170].”
BackgroundLiu, Y., Wu, Q., Shao, J., Mei, Y., Zhang, J., Xu, Q., & Mao, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1568722 · Cited by 13
“However, the lipid metabolism mechanism of ApoE − / − mice differs signi fi cantly from that of humans, with disease progression being driven by VLDL rather than LDL and abnormally high HDL levels (176, 177).”
Kozłowska, A., Wojtacha, P., Majewski, M. S., & Równiak, M. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02312-0 · Cited by 11
Goulart, M. T., Busnardo, C., Belém-Filho, I. J. A., Benini, R., Fassini, A., Crestani, C. C., de Godoy, A. C. V., Corrêa, F. M. D. A., & Alves, F. H. F. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110598 · Cited by 11
Tukhovskaya, E. A., Ismailova, A. M., Perepechenova, N. A., Слащева, Г. А., Паликов, В. А., Palikova, Y. A., Rzhevsky, D. I., Rykov, V. A., Novikova, N. I., Dyachenko, I. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011216 · Cited by 11
“…of the cardiovascular system, such as myocardial infarctions and strokes, studies on the effects of various drugs on blood pressure, with or without hypertension modeling, are mainly carried out on males, since the hormonal cycles of females can influence blood pressure values [45,57,66–71].”
BackgroundBazzigaluppi, P., Beckett, T. L., Koletar, M. M., Hill, M. E., Lai, A. Y., Trivedi, A. U., Thomason, L. A. M., Dorr, A. E., Gallagher, D., Librach, C. L., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13187 · Cited by 11
“In particular, l-NAME is a selective NOS inhibitor, and the decreased level of NO during l-NAME administration could be seen as confounding.(22)”
BackgroundMethodMariano, L. N. B., Boeing, T., Filho, V. C., Niero, R., da Silva, L. M., & de Souza, P. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab026 · Cited by 11
da Silva, A. C. A., Severo, J. S., dos Santos, B. L. B., Mendes, P. H. M., Nobre, L. M. S., de Oliveira, A. P., Ferreira, F. C. S., Medeiros, J. V. R., Lima‐Júnior, R. C. P., Havt, A., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.734038 · Cited by 12
Proteus Syndrome: a difficult diagnosis and management plan.
Popescu, M. D., Burnei, G., Drăghici, L., & Draghici, I. M. (2014) · PubMed Central · Cited by 15
Handayani, D., & Widyaningsih, T. D. (2017) · Research Journal of Life Science · doi:10.21776/ub.rjls.2017.004.03.1 · Cited by 13
Ramachandran, C. D., Gholami, K., Lam, S. K., & Hoe, S.-Z. (2020) · PeerJ · doi:10.7717/peerj.8528 · Cited by 10
Lee, H., Nam, J., Jang, H., Park, Y., Son, M., Lee, I., Eyun, S., Yang, J., Jeon, J., & Yang, S. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16359 · Cited by 10
“…which have shorter life cycles than humans, can be studied throughout their lifespan and through generations, facilitating the generation of the knowledge essential for understanding disease processes and how they interact with living biological systems (Kiani et al., 2022; Leong et al., 2015).”
BackgroundDoumouchtsis, E. K., Tzani, A. I., Doulamis, I. P., Konstantopoulos, P. S., Κορού, Λ.-Μ., Agrogiannis, G., Agapitos, E. B., Moschos, M. M., Kostakis, A. I., & Perrea, D. N. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2017.1356417 · Cited by 9
Ceballos-Gutiérrez, A., Rodríguez‐Hernández, A., Álvarez-Valadez, M. D. R., Limón-Miranda, S., Andrade, F., Figueroa-Gutiérrez, A., Díaz‐Reval, I., Apolinar-Iribe, A., Castro‐Sánchez, L., Alamilla, J., et al. (2021) · Nanomaterials · doi:10.3390/nano11092319 · Cited by 9
“However, three months later, the total cholesterol and HDL-C increased significantly to 29% and 81% respectively compared to the control group (Table 1).”
BackgroundInfluential
Metadata
- Authors
- Leong, X.-F., Ng, C.-Y., & Jaarin, K.
- Affiliations
- University Kebangsaan Malaysia Medical Centre (MY)
- Corresponding author
- Jaarin, Kamsiah
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-11
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4433641
- OpenAlex
- W2005598022
- Cited by
- 203
- References
- 133
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 16 · 2023: 16 · 2022: 20 · 2021: 28 · 2020: 25 · 2019: 26 · 2018: 21 · 2017: 22 · 2016: 12 · 2015: 1
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- animal models, hypertension, atherosclerosis, cardiovascular disease, model validation, drug efficacy, pathophysiology, translational research
- MeSH terms
- Animals, Disease Models, Animal, Humans, Hypertension, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.